ALERT: - Canadian Medication Recall Advisory

"Health Canada is informing Canadians that Apotex Incorporated is conducting a voluntary recall of one lot of Apo-Ramipril 5mg Capsules used to treat hypertension (high blood pressure). The recall of Lot JR2178 was made to retail outlets across Canada.

Medication in the affected lot being recalled has been found to contain intact but empty capsules - meaning that patients taking them may not receive the dose of medication needed to treat their medical condition.

Without appropriate treatment, hypertension may lead to heart attack, stroke, kidney problems, internal bleeding and improper blood circulation. Although Apo-Ramipril is authorized for treatment of hypertension, the ingredient in this medication may also be prescribed for patients who have recently had a heart attack, or who are at high risk of heart attack or stroke."

Who is affected:

"Canadians who have purchased the affected lot of Apo-Ramipril 5mg Capsules. Affected products bear the drug identification number (DIN 02251574) and are from Lot JR2178."

CLICK HERE to read the entire notification from Health Canada...

A "StrokeNewz" survivor awareness announcement